KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Net Income - Minority (2016 - 2024)

Historic Net Income - Minority for Bristol Myers Squibb (BMY) over the last 12 years, with Q3 2024 value amounting to -$58.0 million.

  • Bristol Myers Squibb's Net Income - Minority changed N/A to -$58.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$58.0 million, marking a year-over-year change of. This contributed to the annual value of -$60.0 million for FY2020, which is 4000.0% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Net Income - Minority of -$58.0 million as of Q3 2024.
  • Over the past 5 years, Bristol Myers Squibb's Net Income - Minority peaked at -$54.0 million during Q2 2024, and registered a low of -$72.0 million during Q3 2020.
  • In the last 3 years, Bristol Myers Squibb's Net Income - Minority had a median value of -$66.0 million in 2020 and averaged -$64.6 million.
  • In the last 5 years, Bristol Myers Squibb's Net Income - Minority soared by 4000.0% in 2020 and then tumbled by 303.03% in 2021.
  • Bristol Myers Squibb's Net Income - Minority (Quarter) stood at -$60.0 million in 2020, then dropped by 18.33% to -$71.0 million in 2021, then rose by 18.31% to -$58.0 million in 2024.
  • Its Net Income - Minority stands at -$58.0 million for Q3 2024, versus -$54.0 million for Q2 2024 and -$71.0 million for Q3 2021.